Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 6.3% on ...

Shares of genomics company Illumina (NASDAQ ... would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock dropped 8.6% on ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Caprock Group LLC raised its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 3.7% in the 4th quarter, according to the ...

Shares of genomics company Illumina (NASDAQ ... but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock ...

A number of other institutional investors and hedge funds have also made changes to ... weighed in on the stock. Morgan Stanley cut their price objective on shares of Illumina from $156.00 to ...

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...

Shares of genomics company Illumina (NASDAQ ... but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 3 days ago when the stock ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

This reflects how the analysts covering the stock have collectively ... to an estimated 'Revenue- Core Illumina' of $1.07 billion. The estimate points to a change of -2.5% from the year-ago ...

Investors should keep in mind that an aggregate change may not ... On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that Illumina will most likely ...